Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Extension Study To Assess The Safety Of A Fixed Dose Of Subcutaneous Methylnaltrexone In Subjects With Advanced Illness And Opioid-Induced Constipation

NCT00672139 is registered in ClinicalTrials.gov with Bausch Health Americas, Inc. as lead sponsor.

NCT NCT00672139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00672139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Extension Study To Assess The Safety Of A Fixed Dose Of Subcutaneous Methylnaltrexone In Subjects With Advanced Illness And Opioid-Induced Constipation
Lead sponsor
Bausch Health Americas, Inc.
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2008
Completion date
May 31, 2013
Enrollment
156 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-induced constipation